Status:
COMPLETED
Adaptive Radiation Therapy for Head & Neck Cancer Patients
Lead Sponsor:
Beth Israel Medical Center
Conditions:
Cancer of Head and Neck
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the utility of kilovoltage (kV) cone beam CT imaging to track the dose delivered in head and neck cancer patients, to assess the benefit of cone beam CT to pa...
Detailed Description
The investigators' secondary objectives for this study are to assess the possibility of using kV cone beam for treatment replanning as compared to standard the treatment planning, to determine the nee...
Eligibility Criteria
Inclusion
- Patients should have an ECOG (Eastern Clinical Oncology Group) performance status of 0-2
- Patients should meet at least one of the following criteria:
- Locally advanced cancer (T3-T4 and/or N2-N3)
- Tumors wrapping around critical structures such as the optic nerves, optic chiasm, or brainstem
- Significant expected weight loss.
Exclusion
- Previous surgical procedure more significant than a biopsy to the primary tumor or regional lymph nodes.
- Poor renal function (inability to undergo a CT with IV contrast)
- Previous radiation therapy to the head and neck.
- Inability to tolerate prolonged immobilization.
- Children and women who are pregnant or decline to use contraception.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01853670
Start Date
August 1 2009
End Date
January 1 2015
Last Update
March 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Medical Center
New York, New York, United States, 10003